CARUGNO, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 9.734
NA - Nord America 5.691
EU - Europa 3.977
SA - Sud America 1.093
Continente sconosciuto - Info sul continente non disponibili 520
AF - Africa 212
OC - Oceania 41
Totale 21.268
Nazione #
US - Stati Uniti d'America 5.412
VN - Vietnam 3.477
SG - Singapore 2.262
IT - Italia 1.699
CN - Cina 1.342
HK - Hong Kong 1.036
BR - Brasile 793
RU - Federazione Russa 628
IE - Irlanda 368
BD - Bangladesh 339
DE - Germania 280
KR - Corea 267
IN - India 229
FR - Francia 171
ID - Indonesia 152
GB - Regno Unito 150
NL - Olanda 150
SE - Svezia 149
CA - Canada 130
AR - Argentina 105
FI - Finlandia 77
IQ - Iraq 67
MX - Messico 67
TR - Turchia 65
PK - Pakistan 64
ZA - Sudafrica 58
ES - Italia 53
CO - Colombia 51
PH - Filippine 51
AT - Austria 49
JP - Giappone 48
SA - Arabia Saudita 45
MY - Malesia 44
UA - Ucraina 40
TH - Thailandia 35
AU - Australia 34
EC - Ecuador 34
MA - Marocco 33
UZ - Uzbekistan 31
CL - Cile 29
PL - Polonia 27
ET - Etiopia 22
KE - Kenya 22
VE - Venezuela 22
IR - Iran 21
AE - Emirati Arabi Uniti 20
AF - Afghanistan, Repubblica islamica di 19
CH - Svizzera 19
UY - Uruguay 19
JO - Giordania 17
NP - Nepal 17
TN - Tunisia 17
PY - Paraguay 16
JM - Giamaica 15
PT - Portogallo 15
BO - Bolivia 14
AL - Albania 13
PA - Panama 13
CR - Costa Rica 12
LT - Lituania 12
RO - Romania 11
AZ - Azerbaigian 10
PE - Perù 10
RS - Serbia 10
EG - Egitto 9
IL - Israele 9
NG - Nigeria 9
TT - Trinidad e Tobago 9
TW - Taiwan 9
BE - Belgio 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
KZ - Kazakistan 8
OM - Oman 8
SY - Repubblica araba siriana 7
DO - Repubblica Dominicana 6
NZ - Nuova Zelanda 6
AO - Angola 5
BG - Bulgaria 5
CD - Congo 5
GR - Grecia 5
HN - Honduras 5
HR - Croazia 5
PS - Palestinian Territory 5
GT - Guatemala 4
KG - Kirghizistan 4
LU - Lussemburgo 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
YE - Yemen 4
AM - Armenia 3
BB - Barbados 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
SV - El Salvador 3
CI - Costa d'Avorio 2
DK - Danimarca 2
Totale 20.700
Città #
Singapore 1.307
Ho Chi Minh City 1.092
Hong Kong 1.022
Hanoi 962
San Jose 870
Ashburn 560
Hefei 522
Milan 441
Dublin 355
New York 326
Santa Clara 299
Seoul 262
Council Bluffs 197
Los Angeles 192
Chicago 165
Rome 155
The Dalles 154
Chandler 148
Dallas 131
Da Nang 130
Frankfurt am Main 130
Lauterbourg 102
Beijing 97
Boardman 96
Jakarta 88
Haiphong 84
Buffalo 81
São Paulo 79
Quận Bình Thạnh 74
Biên Hòa 67
Moscow 67
Thái Nguyên 62
Ninh Bình 55
Ha Long 54
Vũng Tàu 51
Nuremberg 48
Helsinki 45
Hải Dương 43
Naples 43
Orem 41
Turin 40
West Jordan 40
Bắc Ninh 39
Can Tho 39
Quận Một 38
Bologna 34
Phoenix 34
Rio de Janeiro 34
Figino 33
Seattle 33
Amsterdam 32
Atlanta 32
Bắc Giang 32
Baghdad 31
Toronto 31
Denver 30
London 30
Brooklyn 29
Quận Phú Nhuận 29
Tokyo 29
Montreal 28
Florence 26
Kent 26
Lappeenranta 26
Shanghai 26
Tashkent 25
Munich 24
San Francisco 24
Vinh 24
Vĩnh Tường 24
Genoa 23
Houston 23
Hòa Bình 23
Lang Son 23
Vienna 23
Warsaw 23
Bangkok 22
Phủ Lý 22
Sydney 22
Chennai 21
Mexico City 21
Lấp Vò 20
Brescia 19
Dhaka 19
Guangzhou 19
Kuala Lumpur 19
Quận Bảy 19
Jeddah 18
Lahore 18
Manila 18
Nairobi 18
Curitiba 17
Johannesburg 17
Montevideo 17
Paris 17
Salt Lake City 17
Belo Horizonte 16
Huizen 16
Riyadh 16
Bari 15
Totale 12.200
Nome #
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 1.640
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 638
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 549
Esperienza del centro di Bergamo 435
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 424
Burden Clinico della Psoriasi Burden Psicologico della Psoriasi 405
Esposizione e discussione della casistica bergamasca 402
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 383
Epidemiological, Phenotypic, Histological, and Genetic Traits in Multiple and Familial Melanomas: a study of 333 cases 375
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 359
51042 Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 357
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 339
Profilo super responder in corso di trattamento con bimekizumab: studio retrospettivo multicentrico nella psoriasi moderato-grave 302
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 271
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 269
Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management 250
Sfide terapeutiche ed esperienze a confronto 249
Addictive behavior and diseases in patients with chronic skin diseases: preliminary findings of a cross-sectional study in Europe 248
Italian guidelines in diagnosis and treatment of alopecia areata 247
Awareness of obesity among patients with psoriasis 238
Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study 234
Ambulatori multidisciplinari 230
Esposizione e discussione dell’esperienza del centro con focalizzazione sui temi controversi 227
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 219
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: A 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis) 218
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients 215
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma 210
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis) 207
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 Patients 203
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis) 200
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 196
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis) 190
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 189
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis) 187
Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features 182
Diagnostic Imaging of Agminated Blue Lesions and Blue Lesions with Satellitosis: Case Series with a Concise Review of the Current Literature 182
HIV and mpox: evaluation of clinical course and outcomes from an international dermatologic registry 174
Diagnosis and management of cutaneous and anogenital lichen sclerosus: Recommendations from the Italian Society of Dermatology (SIDemaSt) 174
“Learning to fly”: quando la pratica supera la teoria. La casistica dei centri 173
Monkeypox: an Italian, multicenter study of 104 cases 168
Monitoraggio epidemiologico di un corso di e-learning per medici di medicina generale all’interno del Melanoma Multimedia Education Programme 167
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 161
Midline Anterior Neck Inclusion Cyst in a Pediatric Patient: A Case Report and Literature Review with a Dermatologic Perspective 160
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach 158
Arrhythmias and other cardiovascular diseases in young patients (<40 years) with moderate/severe atopic dermatitis: A multicentric study in northern Italy 158
Italian guidelines for therapy of atopic dermatitis—Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) 157
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 155
Childhood Pemphigus Vulgaris during COVID-19 Outbreak Successfully Treated with Prednisone and Azathioprine: A Case Report and Literature Review 155
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 152
Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 151
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study 150
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals 148
Epidemiological, Phenotypical, Histological and Genetic Characteristics of Patients with Multiple Melanomas: Study of 108 patients at ASST Papa Giovanni XXIII, Bergamo 148
Monkeypox nell’esperienza del gruppo MTS 148
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 147
A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring 147
Adult-onset tufted angiomas associated with an arteriovenous malformation in a renal transplant recipient: Case report and review of the literature 145
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study 143
Safety of anti-IL-23 risankizumab treatment in a patient with severe psoriasis and Charcot-Marie-Tooth disease 142
Mycosis fungoides: Association of KIR ligands and HLA-DQB1∗05 with bad prognosis of the disease 140
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 140
Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19) 139
Narrowband UVB phototherapy for pediatric generalized pityriasis lichenoides 137
Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience 137
COVID-19 and biologics for psoriasis: A high-epidemic area experience—Bergamo, Lombardy, Italy 136
Use of anti Il-23 p19 inhibitors in cancer patients with severe psoriasis, a multicentric Italian experience 133
Agreement on classification of clinical photographs of pigmentary lesions: Exercise after a training course with young dermatologists 132
Trattamento della psoriasi in placche in soggetti con infezione da HIV con inibitori della IL-23: dati di efficacia e sicurezza nel medio-lungo termine 132
Vasculitides with cutaneous expression in children: Clinico-pathological correlations 131
Hepatitis C infection in Italian psoriatic patients: Prevalence and correlation with patient age and psoriasis severity 128
La diagnosi clinica, il ruolo del dermatologo 127
Patients with bullous skin disease in a high-epidemic COVID-19 area, Bergamo, Italy 127
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 125
Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient 123
Efficacia e sicurezza dei farmaci anti IL 23 nel trattamento della psoriasi in placche in soggetti con infezione da HIV 123
Usefulness of in vivo photodiagnosis for the identification of tumor margins in recurrent basal cell carcinoma of the face 122
RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study 122
Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17? 120
Genetic telecounseling: evaluation of efficacy and outcomes through the Genetic Counseling Outcome Scale (GCOS) questionnaire in a cohort of patients with a suspected melanoma susceptibility syndrome 120
Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer 120
An unconventional case of scurvy 119
Mpox first skin lesion location: a reflection of mode of transmission? 119
Mpox in persons living with HIV: results from an international dermatologic registry 119
Eruptive xanthomas after extensive tattooing: A case report and literature review 118
Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy 116
La terapia topica 116
Artrite psoriasica ed early PsA Il paziente giovane/naive - casi clinici Il paziente sovrappeso/obeso - casi clinici Il paziente con comorbidità 115
Patogenesi: cosa è utile sapere? 114
IgA anti-epidermal transglutaminase autoantibodies: A sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients 113
Cutaneous blastic plasmacytoid dendritic cell neoplasm: Successful palliative treatment with oral prednisone in an elderly patient 113
Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: A paediatric case 113
Metronidazole-induced linear immunoglobulin A disease in a patient suffering from ulcerative colitis: a case report and focused review of the literature 111
IgA anti-epidermal transglutaminase autoantibodies: A simple test to improve differential diagnosis between dermatitis herpetiformis and atopic dermatitis 110
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 110
Rapid remission of atypical cutaneous lobular breast cancer metastases after aromatase inhibitor therapy: a case report and literature review 110
Factors associated with hospitalization due to COVID-19 in patients with psoriasis: insights from a global registry 109
Specific IgE to Staphylococcus aureus superantigens in patients affected by bullous pemphigoid 109
Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients 108
Risankizumab: un nuovo modo di gestire la malattia psoriasica 107
No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy 106
Totale 20.219
Categoria #
all - tutte 66.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.564


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023880 0 176 73 29 83 131 150 72 74 16 54 22
2023/20241.655 44 52 51 38 120 414 235 75 134 130 176 186
2024/20256.230 250 471 413 274 351 212 405 152 359 576 432 2.335
2025/202611.086 2.179 1.447 666 965 825 419 1.529 396 680 771 440 769
2026/20271.417 406 624 387 0 0 0 0 0 0 0 0 0
Totale 21.268